SHARED MEDICAL SYSTEMS CORP
SC TO-T, 2000-06-21
COMPUTER INTEGRATED SYSTEMS DESIGN
Previous: SENSORMATIC ELECTRONICS CORP, 424B3, 2000-06-21
Next: SHARED MEDICAL SYSTEMS CORP, SC TO-T, EX-99.1, 2000-06-21




                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                               AMENDMENT NO. 4 TO
                                   SCHEDULE TO
                             TENDER OFFER STATEMENT
    UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934

                       SHARED MEDICAL SYSTEMS CORPORATION
                       (Name of Subject Company (Issuer))

                        AUTOBAHN ACQUISITION CORPORATION
                          A WHOLLY OWNED SUBSIDIARY OF
                               SIEMENS CORPORATION
                     AN INDIRECT WHOLLY OWNED SUBSIDIARY OF
                           SIEMENS AKTIENGESELLSCHAFT
                        (Name of Filing Person (Offeror))

                                  COMMON STOCK,
                                 PAR VALUE $0.01
                                    PER SHARE
                         (Title of Class of Securities)

                                    819486101
                      (CUSIP Number of Class of Securities)


                                KENNETH R. MEYERS
                               SIEMENS CORPORATION
                               153 EAST 53RD STREET
                            NEW YORK, NEW YORK 10022
                                 (212) 258-4000

                                 with a copy to:

                         BENJAMIN F. STAPLETON III, ESQ.
                               SULLIVAN & CROMWELL
                                125 BROAD STREET
                          NEW YORK, NEW YORK 10004-2498
                                 (212) 558-4000
           (Name, address, and telephone numbers of person authorized
       to receive notices and communications on behalf of filing persons)

--------------------------------------------------------------------------------
                            CALCULATION OF FILING FEE
Transaction valuation                                       Amount of filing fee
Not Applicable
--------------------------------------------------------------------------------

Check the appropriate boxes below to designate any transactions to which the
statement relates:
         [X] third-party tender offer subject to Rule 14d-1.
         [ ] issuer tender offer subject to Rule 13e-4.
         [ ] going-private transaction subject to Rule 13e-3.
         [ ] amendment to Schedule 13D under Rule 13d-2.

Check the following box if the filing is a final amendment reporting the results
of the tender offer: [ ]


<PAGE>

ITEMS 1 - 10.

N/A

ITEM 11.  ADDITIONAL INFORMATION.

          N/A

ITEM 12.  MATERIAL TO BE FILED AS EXHIBITS.

     Item 12 is hereby amended to add the following:

(1)  Press release issued by Siemens Medical Engineering Group, dated June 21,
     2000, announcing that the German Federal Cartel Office intends to terminate
     the in-depth review and to clear the transaction under the German merger
     control laws applicable to Siemens Corporation's pending acquisition of
     Shared Medical Systems Corporation by June 30.

<PAGE>
                                   SIGNATURE

         After due inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.

Date:  June 21, 2000                         Autobahn Acquisition Corporation

                                                   /s/ Michael W. Schiefen
                                             -----------------------------------
                                             Name: Michael W. Schiefen
                                             Title: President

                                                  /s/ E. Robert Lupone
                                             -----------------------------------
                                             Name: E. Robert Lupone
                                             Title: Vice President

                                             Siemens Corporation

                                                 /s/ Michael W. Schiefen
                                             -----------------------------------
                                             Name: Michael W. Schiefen
                                             Title: Vice President-Corporate
                                             Development

                                                /s/ E. Robert Lupone
                                             -----------------------------------
                                             Name: E. Robert Lupone
                                             Title: Vice President, General
                                             Counsel and Secretary

                                             Siemens Aktiengesellschaft

                                                /s/ Goetz Steinhardt
                                             -----------------------------------
                                             Name: Goetz Steinhardt
                                             Title: Corporate Vice President
                                             Group Executive Medical Engineering

                                                /s/ Robert Kirschbaum
                                             -----------------------------------
                                             Name: Robert Kirschbaum
                                             Title: Corporate Legal Counsel


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission